JP2003119141A - 吸収性を向上した経口投与製剤 - Google Patents

吸収性を向上した経口投与製剤

Info

Publication number
JP2003119141A
JP2003119141A JP2001313977A JP2001313977A JP2003119141A JP 2003119141 A JP2003119141 A JP 2003119141A JP 2001313977 A JP2001313977 A JP 2001313977A JP 2001313977 A JP2001313977 A JP 2001313977A JP 2003119141 A JP2003119141 A JP 2003119141A
Authority
JP
Japan
Prior art keywords
vitamin
tocopherol
hepronicate
weight
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001313977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003119141A5 (enExample
Inventor
Minoru Okada
実 岡田
Haruo Sugata
晴夫 菅田
Toshiaki Horie
敏彰 堀江
Tetsuo Kaneko
哲男 金子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP2001313977A priority Critical patent/JP2003119141A/ja
Priority to TW091120354A priority patent/TWI244921B/zh
Priority to CNB021439834A priority patent/CN1219514C/zh
Priority to KR1020020060903A priority patent/KR20030030882A/ko
Publication of JP2003119141A publication Critical patent/JP2003119141A/ja
Priority to HK03107057.2A priority patent/HK1054695B/xx
Publication of JP2003119141A5 publication Critical patent/JP2003119141A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2001313977A 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤 Pending JP2003119141A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤
TW091120354A TWI244921B (en) 2001-10-11 2002-09-05 Oral administration medicine with improving absorbability
CNB021439834A CN1219514C (zh) 2001-10-11 2002-09-29 具有高吸收性的口服制剂
KR1020020060903A KR20030030882A (ko) 2001-10-11 2002-10-07 흡수성을 향상시킨 경구투여 제제
HK03107057.2A HK1054695B (en) 2001-10-11 2003-09-30 Oral administration preparation improved in absorbability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Publications (2)

Publication Number Publication Date
JP2003119141A true JP2003119141A (ja) 2003-04-23
JP2003119141A5 JP2003119141A5 (enExample) 2005-06-09

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001313977A Pending JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Country Status (4)

Country Link
JP (1) JP2003119141A (enExample)
KR (1) KR20030030882A (enExample)
CN (1) CN1219514C (enExample)
TW (1) TWI244921B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032552A1 (ja) * 2003-09-30 2005-04-14 Kobayashi Pharmaceutical Co., Ltd. 催眠剤組成物
WO2005032546A1 (ja) * 2003-09-30 2005-04-14 Kobayashi Pharmaceutical Co., Ltd. 催眠剤組成物
JP2010150285A (ja) * 2010-03-23 2010-07-08 Kobayashi Pharmaceutical Co Ltd 催眠剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032552A1 (ja) * 2003-09-30 2005-04-14 Kobayashi Pharmaceutical Co., Ltd. 催眠剤組成物
WO2005032546A1 (ja) * 2003-09-30 2005-04-14 Kobayashi Pharmaceutical Co., Ltd. 催眠剤組成物
JP2005104926A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 催眠剤組成物
JP2005104927A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 催眠剤組成物
JP2010150285A (ja) * 2010-03-23 2010-07-08 Kobayashi Pharmaceutical Co Ltd 催眠剤組成物

Also Published As

Publication number Publication date
CN1219514C (zh) 2005-09-21
CN1411812A (zh) 2003-04-23
KR20030030882A (ko) 2003-04-18
TWI244921B (en) 2005-12-11
HK1054695A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
JP2602947B2 (ja) ジホスホン酸誘導体経口医薬組成物
RU2469728C2 (ru) Способ лечения дефицита витамина b12
MXPA01008549A (es) Metodos de tratamiento de desordenes mitocondriales.
JPH031287B2 (enExample)
US20130084272A1 (en) Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
EP1541141A1 (en) Therapeutic agent for hepatic disease
TW202025997A (zh) 正常化胺基酸代謝的方法
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
JPH10287560A (ja) 医薬組成物
JPWO2007046347A1 (ja) 筋萎縮性側索硬化症患者の運動神経保護用医薬
AU730675B2 (en) Stable, solid preparation comprising vitamin D3 and tricalcium phosphate
US20070197647A1 (en) Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients
JP2003119141A (ja) 吸収性を向上した経口投与製剤
JPH04327537A (ja) 組織における充分な細胞内グルタチオンを保証する方法
JPH05339148A (ja) 血液脳関門を通過する物質
JP4989836B2 (ja) 経口栄養剤
US20060216361A1 (en) Compositions and methods for the treatment of osteoporosis and inflammatory joint disease
JP2011068647A (ja) アスパラギン酸又はその塩含有固形製剤
US20080153831A1 (en) Isoflavone-containing compositions for the treatment of osteoporosis and inflammatory joint disease
JPH0826982A (ja) 骨粗鬆症予防・治療剤
JPH05294833A (ja) ビタミン含有保健剤
Yagil et al. The hypertensive effect of an oral adenosine analog with selectivity for the A2 receptor in the spontaneously hypertensive rat
KR20250079770A (ko) 호모해링토닌이 탑재된 cd9 항체 결합 나노입자 및 이의 용도
JPH09143088A (ja) 滋養強壮保健剤
JP2003119135A (ja) 血行改善薬

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080527

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081007